Cited by 899Cancer, Hypoxia, and MetabolismCancer Immunotherapy and BiomarkersImmune cells in cancer

The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.

Metabolism of immune cells in cancer

Open access

Leone, Robert D., Powell, Jonathan D.·2020·Nature Reviews Cancer

DOI 10.1038/s41568-020-0273-yPMC PMC8041116

Open this paper in CoChat — free account

Abstract

Through the successes of checkpoint blockade and adoptive cellular therapy, immunotherapy has become an established treatment modality for cancer. Cellular metabolism has emerged as a critical determinant of the viability and function of both cancer cells and immune cells. In order to sustain prodigious anabolic needs, tumours employ a specialized metabolism that differs from untransformed somatic cells. This metabolism leads to a tumour microenvironment that is commonly acidic, hypoxic and/or depleted of critical nutrients required by immune cells. In this context, tumour metabolism itself is a checkpoint that can limit immune-mediated tumour destruction. Because our understanding of immune cell metabolism and cancer metabolism has grown significantly in the past decade, we are on the cusp of being able to unravel the interaction of cancer cell metabolism and immune metabolism in therapeutically meaningful ways. Although there are metabolic processes that are seemingly fundamental to both cancer and responding immune cells, metabolic heterogeneity and plasticity may serve to distinguish the two. As such, understanding the differential metabolic requirements of the diverse cells that comprise an immune response to cancer offers an opportunity to selectively regulate immune cell function. Such a nuanced evaluation of cancer and immune metabolism can uncover metabolic vulnerabilities and therapeutic windows upon which to intervene for enhanced immunotherapy. This Review discusses our current understanding of adaptive and innate immune cell metabolism in the context of the tumour microenvironment, providing insight into the interaction of cancer cell metabolism and immune metabolism, as well as the potential for leveraging metabolic vulnerabilities to enhance the antitumour immune response.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41568-020-0273-y

Cites

229 of 229 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation
Moon, J.-S., Hisata, S., Park, M. A., DeNicola, G. M., Ryter, S. W., Nakahira, K., & Choi, A. M. K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.046 · Cited by 379
Retracted
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046
Mitochondrial TCA cycle metabolites control physiology and disease
Martínez-Reyes, I., & Chandel, N. S. (2020) · Nature Communications · doi:10.1038/s41467-019-13668-3 · Cited by 2,813
Physiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I. E., Conway, S. J., Marshall, B., Brown, C. C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,589

Show all 228 references

Sorted by citations

Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,477
Cancer metabolism: looking forward
Martínez‐Reyes, I., & Chandel, N. S. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,877
Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells
Xiong, J., He, J., Zhu, J., Pan, J., Liao, W., Ye, H., Wang, H., Song, Y., Du, Y. J., Cui, B., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.033 · Cited by 839
Metabolic programming and immune suppression in the tumor microenvironment
Arner, E. N., & Rathmell, J. C. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.01.009 · Cited by 715
The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions
Lei, G., Zhuang, L., & Gan, B. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.03.011 · Cited by 635
Resistance Mechanisms to Anti-PD Cancer Immunotherapy
Vesely, M. D., Zhang, T., & Chen, L. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-070621-030155 · Cited by 468
Metabolism of Amino Acids in Cancer
Wei, Z. C., Liu, X., Cheng, C., Yu, W., & Yi, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603837 · Cited by 456
Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer
Sun, C., Wang, A., Zhou, Y., Chen, P., Wang, X., Huang, J., Gao, J., Wang, X. D., Shu, L., Lu, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38360-5 · Cited by 352
CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis
Yang, P., Qin, H., Li, Y., Xiao, A., Zheng, E., Zeng, H., Su, C., Luo, X., Lu, Q., Liao, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33349-y · Cited by 346
Cancer cell metabolism and antitumour immunity
Martino, M. D., Rathmell, J. C., Galluzzi, L., & Vanpouille‐Box, C. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01026-4 · Cited by 385
Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications
Zhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 356
Hyaluronan: Metabolism and Function
Kobayashi, T., Chanmee, T., & Itano, N. (2020) · Biomolecules · doi:10.3390/biom10111525 · Cited by 321
Programmed Cell Death Tunes Tumor Immunity
Liu, J., Hong, M., Li, Y., Chen, D., Wu, Y., & Hu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847345 · Cited by 330
Therapeutic targeting of tumour myeloid cells
Barry, S. T., Gabrilovich, D. I., Sansom, O. J., Campbell, A. D., & Morton, J. P. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00546-2 · Cited by 305
Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment
Tharp, K. M., Kersten, K., Maller, O., Timblin, G. A., Stashko, C., Canale, F. P., Menjivar, R. E., Hayward, M.-K., Berestjuk, I., ten Hoeve, J., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00775-4 · Cited by 336
STAT proteins in cancer: orchestration of metabolism
Li, Y., Zhang, C., Martincuks, A., Herrmann, A., & Yu, H. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-022-00537-3 · Cited by 305
Promises and challenges of adoptive T-cell therapies for solid tumours
Morotti, M., Albukhari, A., Alsaadi, A., Artibani, M., Brenton, J. D., Curbishley, S. M., Dong, T., Dustin, M. L., Hu, Z., McGranahan, N., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01353-6 · Cited by 278
The complexity of p53-mediated metabolic regulation in tumor suppression
Liu, Y., & Gu, W. J. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.010 · Cited by 267
TGF-β signaling in the tumor metabolic microenvironment and targeted therapies
Shi, X., Yang, J., Deng, S., Xu, H., Wu, D., Zeng, Q., Wang, S., Hu, T., Wu, F., & Zhou, H. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01349-6 · Cited by 262
Emerging therapies in cancer metabolism
Xiao, Y., Yu, T., Xu, Y., Ding, R., Wang, Y.-P., Jiang, Y., & Shao, Z. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.006 · Cited by 279
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
Kundu, M., Butti, R., Panda, V. K., Malhotra, D., Das, S., Mitra, T., Kapse, P., Gosavi, S., & Kundu, G. C. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01990-4 · Cited by 284
Revisiting the HIF switch in the tumor and its immune microenvironment.
Cowman, S. J., & Koh, M. Y. (2022) · Trends in Cancer · doi:10.1016/j.trecan.2021.10.004 · Cited by 256
Metabolic reprogramming in the tumor microenvironment of liver cancer
Lin, J., Rao, D., Zhang, M., & Gao, Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01527-8 · Cited by 251
“With the advent of immunome-tabolism in cancer treatment [18–22], greater attention should be given to the interplay of metabolism-related immune signaling.”
BackgroundInfluential
Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
Kerk, S. A., Papagiannakopoulos, T. Y., Shah, Y. M., & Lyssiotis, C. A. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00375-9 · Cited by 246
ATP and cancer immunosurveillance
Kepp, O., Bezu, L., Yamazaki, T., Virgilio, F. D., Smyth, M. J., Kroemer, G., & Galluzzi, L. (2021) · The EMBO Journal · doi:10.15252/embj.2021108130 · Cited by 238
Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity
Yan, Y., Huang, L., Liu, Y., Yi, M., Chu, Q., Jiao, D., & Wu, K. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01322-3 · Cited by 226
IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment
Hu, B., Yu, M., Ma, X., Sun, J., Liu, C., Wang, C., Wu, S., Fu, P., Yang, Z. F., He, Y., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1022 · Cited by 213
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Xiao, Y.-L., Gong, Y., Qi, Y.-J., Shao, Z., & Jiang, Y.-Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01771-x · Cited by 218
Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance
Ge, R., Wang, Z., & Liang Cheng, C. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00272-w · Cited by 212
Anticancer Activity of Natural and Synthetic Chalcones
Constantinescu, T., & Lungu, C. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111306 · Cited by 197
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
Cui, J., Li, Y., Yang, Y., Yang, H., Dong, J.-M., Xiao, Z.-H., He, X., Guo, J., Wang, R. L., Dai, B., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116203 · Cited by 208
Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy
Nicolini, A., & Ferrari, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1353787 · Cited by 209
The Metabolic Mechanisms of Breast Cancer Metastasis
Wang, L., Zhang, S., & Wang, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.602416 · Cited by 200
Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth
Zhao, H., Teng, D., Yang, L., Xu, X., Chen, J., Jiang, T., Feng, A. Y., Zhang, Y., Frederick, D. T., Gu, L., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00676-9 · Cited by 179
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
Liu, S., Wang, W., Hu, S., Jia, B., Tuo, B., Sun, H., Wang, Q., Liu, Y., & Sun, Z. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06211-2 · Cited by 194
Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studies
Zhao, W., Wang, L., Zhang, M., Liu, Z., Wu, C., Pan, X., Huang, Z., Lu, C. T., & Quan, G. (2024) · MedComm · doi:10.1002/mco2.603 · Cited by 182
Counteracting CAR T cell dysfunction
Poorebrahim, M., Melief, J., de Coaña, Y. P., Wickström, S. L., Arregui, A. C., & Kiessling, R. W. (2020) · Oncogene · doi:10.1038/s41388-020-01501-x · Cited by 172
Single-cell spatial metabolomics with cell-type specific protein profiling for tissue systems biology
Hu, T., Allam, M., Cai, S., Henderson, W. E., Yueh, B., Alici-Garipcan, A., Ievlev, A. V., Afkarian, M., Beyaz, S., & Coskun, A. F. (2023) · Nature Communications · doi:10.1038/s41467-023-43917-5 · Cited by 178
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers
Liang, X., Weng, J., You, Z., Wang, Y., Wen, J., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02375-x · Cited by 204
Effects of Glucose Metabolism, Lipid Metabolism, and Glutamine Metabolism on Tumor Microenvironment and Clinical Implications
Zhu, L., Zhu, X., & Wu, Y. (2022) · Biomolecules · doi:10.3390/biom12040580 · Cited by 167
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
Zhang, H., Li, S., Wang, D., Liu, S. M., Xiao, T., Gu, W., Yang, H., Wang, H. Z., Yang, M., & Chen, P. (2024) · Biomarker Research · doi:10.1186/s40364-024-00646-1 · Cited by 178
Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?
Xu, Y., Xue, D., Bankhead, A., & Neamati, N. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01013 · Cited by 173
Mitochondrial Metabolism Regulation of T Cell–Mediated Immunity
Steinert, E. M., Vasan, K., & Chandel, N. S. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101819-082015 · Cited by 161
Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy
Zheng, Y., Han, Y., Sun, Q., & Li, Z. (2022) · Exploration · doi:10.1002/exp.20210166 · Cited by 151
Clinical development of metabolic inhibitors for oncology
Lemberg, K. M., Gori, S. S., Tsukamoto, T., Rais, R., & Slusher, B. S. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148550 · Cited by 142
The extracellular matrix integrates mitochondrial homeostasis
Zhang, H., Tsui, C. K., Garcia, G., Joe, L. K., Wu, H., Maruichi, A., Fan, W., Pandovski, S., Yoon, P. H., Webster, B. M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.057 · Cited by 139
Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy
Qiu, Q., Lin, Y., Ma, Y., Li, X., Liang, J. B., Chen, Z., Liu, K., Huang, Y., Luo, H., Huang, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612202 · Cited by 140
A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle
Wang, B., Pei, J., Xu, S., Liu, J., & Yu, J. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02994-0 · Cited by 140
Fatty acid metabolism of immune cells: a new target of tumour immunotherapy
Zhang, S., Lv, K., Liu, Z., Zhao, R., & Li, F. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01807-9 · Cited by 141
Vascular Microenvironment, Tumor Immunity and Immunotherapy
Lamplugh, Z. L., & Fan, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.811485 · Cited by 131
Carrier-Free Immunotherapeutic Nano-Booster with Dual Synergistic Effects Based on Glutaminase Inhibition Combined with Photodynamic Therapy
Mai, Z., Zhong, J., Zhang, J., Chen, G., Tang, Y., Ma, W., Li, G., Feng, Z., Li, F., Liang, X., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c11037 · Cited by 124
Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1
Chen, S., Cui, W., Chi, Z., Xiao, Q., Hu, T., Ye, Q., Zhu, K., Yu, W., Wang, Z., Yu, C., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.08.016 · Cited by 123
Biodegradable NIR‐II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor‐Associated Macrophage Reprogramming
Wan, J., Zhang, X., Tang, D., Liu, T., & Xiao, H. (2023) · Advanced Materials · doi:10.1002/adma.202209799 · Cited by 122
Leucine-tRNA-synthetase-2-expressing B cells contribute to colorectal cancer immunoevasion
Wang, Z., Zhou, L., Lin, S., Xia, J., Zhong, Z., Xie, Z., Xing, Y., Qie, J., Jiao, M., Li, Y., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.017 · Cited by 122
Recent advances in biomimetic nanodelivery systems: New brain-targeting strategies
Liao, J., Fan, L., Li, Y., Xu, Q.-Q., Xiong, L., Zhang, S., Liu, J.-H., Xiao, Z.-C., Zhang, C., Yang, J., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.009 · Cited by 119
The Effect of Oxidative Phosphorylation on Cancer Drug Resistance
Zhao, Z., Mei, Y., Wang, Z., & He, W. (2022) · Cancers · doi:10.3390/cancers15010062 · Cited by 128
Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy
Tang, X., Zuo, C., Fang, P., Liu, G., Qiu, Y., Huang, Y., & Tang, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.701291 · Cited by 130
Activation and antitumor immunity of CD8 + T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid
Liu, Y., Wang, F., Peng, D., Zhang, D., Liu, L., Wei, J., Yuan, J., Zhao, L., Jiang, H., Zhang, T., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk7399 · Cited by 127
Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities
Qian, Y., Yin, Y., Zheng, X., Liu, Z., & Wang, X. (2024) · Biomarker Research · doi:10.1186/s40364-023-00549-7 · Cited by 120
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
Huang, K., Han, Y., Chen, Y., Shen, H., Zeng, S., & Cai, C. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02205-6 · Cited by 121
Coordination Polymer‐Coated CaCO3 Reinforces Radiotherapy by Reprogramming the Immunosuppressive Metabolic Microenvironment
Wang, C., Dong, Z., Hao, Y., Zhu, Y., Ni, J., Li, Q., Liu, B., Han, Y., Yang, Z., Wan, J., et al. (2021) · Advanced Materials · doi:10.1002/adma.202106520 · Cited by 112
Metformin Reprograms Tryptophan Metabolism to Stimulate CD8+ T-cell Function in Colorectal Cancer
Huang, X., Sun, T., Wang, J., Hong, X., Chen, H., Yan, T., Zhou, C., Sun, D., Yang, C. G., Yu, T., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3042 · Cited by 113
Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers
Yu, T., Ma, D., Liu, Y., Xiao, Y., Gong, Y., Jiang, Y., Shao, Z.-M., Hu, X., & Di, G. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.003 · Cited by 113
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer
Zhao, L., Liu, Y., Zhang, S., Wei, L., Cheng, H., Wang, J., & Wang, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04821-w · Cited by 115
IL-9/STAT3/fatty acid oxidation–mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity
Xiao, L., Ma, X., Ye, L., Su, P., Xiong, W., Bi, E., Wang, Q., Xian, M., Yang, M., Qian, J., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci153247 · Cited by 111
Ammonia detoxification promotes CD8+ T cell memory development by urea and citrulline cycles
Tang, K., Zhang, H., Deng, J., Wang, D., Liu, S., Lu, S., Cui, Q., Chen, C., Liu, J., Yang, Z., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01365-1 · Cited by 105
Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection
Mu, W., Patankar, V., Kitchen, S. G., & Zhen, A. (2024) · Viruses · doi:10.3390/v16020219 · Cited by 116
Dendritic Nanomedicine with Boronate Bonds for Augmented Chemo‐Immunotherapy via Synergistic Modulation of Tumor Immune Microenvironment
Li, Y., Wu, Y., Fang, Z., Zhang, Y., Haitao, D., Ren, L., Zhang, L., Gong, Q., Gu, Z., & Luo, K. (2023) · Advanced Materials · doi:10.1002/adma.202307263 · Cited by 104
Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis
Huang, X., Pang, M.-J., Li, J.-Y., Chen, H., Sun, J., Song, Y., Ni, H.-J., Ye, S.-Y., Bai, S., Li, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36310-9 · Cited by 115
Dual Tumor Microenvironment Remodeling by Glucose‐Contained Radical Copolymer for MRI‐Guided Photoimmunotherapy
Cheng, H., Fan, X., Ye, E., Chen, H., Yang, J., Ke, L., You, M., Liu, M., Zhang, Y., Wu, Y., et al. (2021) · Advanced Materials · doi:10.1002/adma.202107674 · Cited by 102
Supervised discovery of interpretable gene programs from single-cell data
Kunes, R., Walle, T., Land, M., Nawy, T., & Pe’er, D. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01940-3 · Cited by 106
Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity
Ma, M., Zhang, Y., Pu, K., & Tang, W. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00679h · Cited by 100
Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders
Hu, P., Li, K., Peng, X., Kan, Y., Li, H., Zhu, Y., Wang, Z., Li, Z., Liu, H., & Cai, D. (2023) · Nutrients · doi:10.3390/nu15224772 · Cited by 91
A review of the neurobehavioural, physiological, and reproductive toxicity of microplastics in fishes
Hasan, A. K. M. M., Hamed, M., Hasan, J., Martyniuk, C. J., Niyogi, S., & Chivers, D. P. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116712 · Cited by 96
Chemical Modulation of Glucose Metabolism with a Fluorinated CaCO3 Nanoregulator Can Potentiate Radiotherapy by Programming Antitumor Immunity
Dong, Z., Wang, C., Gong, Y., Zhang, Y., Fan, Q., Hao, Y., Li, Q., Wu, Y., Zhong, X., Yang, K., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c02688 · Cited by 87
ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors
Zhu, H. H., Wang, G., Zhu, H., & Xu, A. (2021) · BMC Cancer · doi:10.1186/s12885-021-07996-1 · Cited by 84
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity
Sharma, M. D., Pacholczyk, R., Shi, H., Berrong, Z., Zakharia, Y., Greco, A., Chang, C.-S. S., Eathiraj, S., Kennedy, E. P., Cash, T., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.09.005 · Cited by 83
IL-9/STAT3/fatty acid oxidation–mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity
Xiao, L., Ma, X., Ye, L., Pan, S., Xiong, W., Bi, E., Wang, Q., Xian, M., Yang, M., Qian, J., et al. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 80
Gut fungi enhances immunosuppressive function of myeloid-derived suppressor cells by activating PKM2-dependent glycolysis to promote colorectal tumorigenesis
Zhang, Z., Zheng, Y., Chen, Y., Yin, Y., Chen, Y., Chen, Q., Hou, Y., Shen, S., Lv, M., & Wang, T. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00334-6 · Cited by 82
The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?
Khouzam, R. A., Zaarour, R. F., Brodaczewska, K. K., Azakir, B., Venkatesh, G. H., Thiery, J., Terry, S., & Chouaı̈b, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.828875 · Cited by 80
Intelligent poly(l-histidine)-based nanovehicles for controlled drug delivery
Zhang, Y., Kim, I., Lu, Y., Xu, Y., Yu, D., & Song, W. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.005 · Cited by 77
The role of glutamate receptors in the regulation of the tumor microenvironment
Koda, S., Hu, J., Ju, X., Sun, G., Shao, S., Tang, R., Zheng, K., & Yan, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1123841 · Cited by 81
Metabolic determinants of tumour initiation
Brunner, J. S., & Finley, L. W. S. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00773-5 · Cited by 78
ATP-exhausted nanocomplexes for intratumoral metabolic intervention and photoimmunotherapy
Yu, M., Zeng, W., Ouyang, Y., Liang, S. M., Yi, Y., Hao, H., Yu, J., Liu, Y., Nie, Y., Wang, T., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121503 · Cited by 75
Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions
Granhøj, J. S., Jensen, A. W. P., Presti, M., Met, Ö., Svane, I. M., & Donia, M. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2064711 · Cited by 76
Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy
Lv, Y., Li, Z., Liu, S., Zhou, Z., Jinling, S., Ba, Y., Weng, S., Zuo, A., Xu, H. W., Luo, P., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02407-6 · Cited by 93
The Role of Metabolic Plasticity of Tumor-Associated Macrophages in Shaping the Tumor Microenvironment Immunity
Hasan, M. N., Capuk, O., Patel, S. M., & Sun, D. (2022) · Cancers · doi:10.3390/cancers14143331 · Cited by 75
Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5
Lai, Y., Gao, Y., Lin, J., Liu, F., Yang, L., Zhou, J. H. S., Xue, Y., Li, Y., Chang, Z., Li, J., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.01.012 · Cited by 76
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Xie, Y., Xie, F., Zhang, L., Zhou, X., Huang, J., Wang, F., Jin, J., Zhang, L., Zeng, L., & Zhou, F. (2021) · Advanced Science · doi:10.1002/advs.202101672 · Cited by 72
Insights into the Effect of Catalytic Intratumoral Lactate Depletion on Metabolic Reprogramming and Immune Activation for Antitumoral Activity
Zhao, J., Tian, Z., Zhao, S., Feng, D., Guo, Z., Wen, L., Zhu, Y., Xu, F., Zhu, J., Ma, S., et al. (2022) · Advanced Science · doi:10.1002/advs.202204808 · Cited by 73
Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Zhou, Y., Yuan, J. T., Xu, K., Li, S., & Liu, Y. (2024) · ACS Nano · doi:10.1021/acsnano.3c11260 · Cited by 73
Advances in and prospects of immunotherapy for prostate cancer
Liu, D., Wang, L., & Guo, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217155 · Cited by 78
Macrophages and T cells in metabolic disorder-associated cancers
Taranto, D., Kloosterman, D. J., & Akkari, L. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00743-1 · Cited by 81
Mitochondrial Localized In Situ Self‐Assembly Reprogramming Tumor Immune and Metabolic Microenvironment for Enhanced Cancer Therapy
Wang, Z., Wang, Q., Cao, H., Wang, Z., Wang, D., Liu, J., Gao, T., Ren, C., & Liu, J. (2024) · Advanced Materials · doi:10.1002/adma.202311043 · Cited by 71
Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A + myeloid cells to promote liver cancer progression
Yang, Y., Pei, T., Liu, C., Cao, M., Hu, X., Yuan, J., Chen, F., Guo, B., Hong, Y., Liu, J., et al. (2024) · Gut · doi:10.1136/gutjnl-2024-332429 · Cited by 78
Multilevel Mechanisms of Cancer Drug Resistance
Roszkowska, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212402 · Cited by 73
Solute carrier transporters: emerging central players in tumour immunotherapy
Chen, R., & Chen, L. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.08.002 · Cited by 69
Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature
He, J., Chen, Z., Xue, Q., Sun, P., Wang, Y., Zhu, C., & Shi, W. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03393-9 · Cited by 68
Composite Hydrogel for Spatiotemporal Lipid Intervention of Tumor Milieu
Ma, J., Guo, D., Ji, X., Zhou, Y., Liu, C., Li, Q., Zhang, J., Fan, C., & Song, H. (2023) · Advanced Materials · doi:10.1002/adma.202211579 · Cited by 65
Optimising NK cell metabolism to increase the efficacy of cancer immunotherapy
Choi, C., & Finlay, D. K. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02377-8 · Cited by 66

Authors: Leone, R. D., & Powell, J. D.
Affiliations: Johns Hopkins University (US)
Corresponding author: Powell, Jonathan D.
ORCID: Leone, Robert D.
Powell, Jonathan D.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2020-07-06
Volume: 20
Issue: 9
Pages: 516-531
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/s41568-020-0273-y
PMC: PMC8041116
OpenAlex: W3040651070
Semantic Scholar: 9e54633c23933564226222b58eee14bffccca97c
Cited by: 877
References: 228
Citations by year: 2026: 137 · 2025: 168 · 2024: 141 · 2023: 135 · 2022: 185 · 2021: 98 · 2020: 12
FWCI: 11.48
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (R01CA229451, R01CA226765)
National Institute of Allergy and Infectious Diseases (R01AI077610)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords: immune cell metabolism, cancer metabolism, tumor microenvironment, tumor acidosis, tumor hypoxia, nutrient depletion, adaptive immunity, innate immunity, metabolic heterogeneity, metabolic plasticity, metabolic vulnerability, immunotherapy, antitumor immunity
MeSH terms: Animals, Humans, Immune System, Immunotherapy, Neoplasms, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metabolism of immune cells in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks